These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 917834

  • 1. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F, Brun B, Mazeron JJ, Rochant H, Pinon G, Reyes F, Vernant JP, Pierquin B, Dreyfus B.
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [Abstract] [Full Text] [Related]

  • 2. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B, Alaoui Y, Kuentz M, Baillet F, Maylin C, Vernant JP, Reyes F, Rochant H, Pierquin B, Dreyfus B.
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P, Hayat M, Cosset JM, Somers R, Burgers JM, Sizoo W, Meerwaldt JH, Hagenbeek A, Monconduit M, van der Schueren E.
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Polychemotherapy of Hodgkin's disease (author's transl)].
    Jacquillat CL, Weil M, Auclerc G, Delbrück H, Chastang CL, Chelloul N, Boiron M, Bernard J.
    Dtsch Med Wochenschr; 1975 Apr 11; 100(15):785-90. PubMed ID: 1122828
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current trend in the treatment of Hodgkin's disease.
    Tubiana M, Amiel JL, Hayat M, Henry-Amar M, Cosset JM, Droz JP, Carde P.
    Radiat Med; 1983 Apr 11; 1(3):221-9. PubMed ID: 6390537
    [Abstract] [Full Text] [Related]

  • 10. The treatment of Hodgkin's disease.
    Fairley GH.
    Trans Med Soc Lond; 1972 Apr 11; 88():61-71. PubMed ID: 4665820
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP, Young RC, Berard CW, DeVita VT.
    Arch Intern Med; 1973 Mar 11; 131(3):388-90. PubMed ID: 4569375
    [No Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F, Baccarani M, Barbieri E, Fiacchini M, Gobbi M, Tura S, Baccarani M.
    Haematologica; 1975 Mar 11; 60(1):73-84. PubMed ID: 806500
    [No Abstract] [Full Text] [Related]

  • 13. [Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
    Jacquillat C, Auclerc G, Gemon-Auclerc MF, Weil M, Chastang C, Boiron M, Bernard J.
    Nouv Rev Fr Hematol Blood Cells; 1977 Mar 11; 18(2):473-83. PubMed ID: 917836
    [No Abstract] [Full Text] [Related]

  • 14. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M, Mathé G.
    Ser Haematol; 1973 Mar 11; 6(2):202-43. PubMed ID: 4206180
    [No Abstract] [Full Text] [Related]

  • 15. [Combined chemotherapy in Hodgkin's disease].
    Somers R, Haanen C, Hart AA, Kroese WF, Sizoo W, Wagener DJ.
    Ned Tijdschr Geneeskd; 1976 Jun 12; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH.
    N Engl J Med; 1974 Dec 12; 291(24):1309. PubMed ID: 4431438
    [No Abstract] [Full Text] [Related]

  • 19. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M.
    Bull Cancer; 1982 Dec 12; 69(4):321-9. PubMed ID: 6897520
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.